This Month in Gastroenterology

Slides:



Advertisements
Similar presentations
This Month in Gastroenterology
Advertisements

Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
Volume 152, Issue 4, Pages (March 2017)
Volume 135, Issue 6, Pages e1 (December 2008)
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
Community Colonoscopy: A Gordian Knot?
Low Rates of Gastrointestinal and Non-Gastrointestinal Complications for Screening or Surveillance Colonoscopies in a Population-Based Study  Louise Wang,
This Month in Gastroenterology
Volume 132, Issue 3, Pages (March 2007)
This Month in Gastroenterology
Outcomes Among Living Liver Donors
This Month in Gastroenterology
Volume 154, Issue 3, Pages (February 2018)
This Month in Gastroenterology
This Month in Gastroenterology
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Our New President—C. Richard Boland, MD
Making Sense of HDAC2 Mutations in Colon Cancer
Volume 140, Issue 5, Pages (May 2011)
This Month in Gastroenterology
Intragastric pH With Oral vs Intravenous Bolus Plus Infusion Proton-Pump Inhibitor Therapy in Patients With Bleeding Ulcers  Loren Laine, Abbid Shah,
Volume 154, Issue 5, Pages (April 2018)
Volume 137, Issue 6, Pages (December 2009)
The Changing Liver Transplant Waitlist: An Emerging Liver Purgatory?
Volume 155, Issue 4, Pages (October 2018)
Amir Klein, Michael J. Bourke  Gastroenterology 
Volume 135, Issue 4, Pages (October 2008)
Volume 150, Issue 4, Pages (April 2016)
Volume 138, Issue 4, Pages e3 (April 2010)
This Month in Gastroenterology
This Month in Gastroenterology
Abrogation of the Antifibrotic Effects of Natural Killer Cells/Interferon-γ Contributes to Alcohol Acceleration of Liver Fibrosis  Won–Il Jeong, Ogyi.
Hepatitis C and Hepatocellular Carcinoma: Grist for the Mill
Volume 144, Issue 2, Pages (February 2013)
Volume 138, Issue 7, Pages e3 (June 2010)
This Month in Gastroenterology
This Month in Gastroenterology
This Month in Gastroenterology
Daniel F. Wallace, Lesa Summerville, V. Nathan Subramaniam 
This Month in Gastroenterology
Laura Rotundo, Sushil Ahlawat  Gastroenterology 
Volume 134, Issue 7, Pages (June 2008)
Patient, Procedure, and Endoscopist Risk Factors for Perforation, Bleeding, and Splenic Injury After Colonoscopies  Moussa Laanani, Joël Coste, Pierre-Olivier.
This Month in Gastroenterology
Volume 131, Issue 6, Pages (December 2006)
Reduced Mortality Rates Following Elective Percutaneous Liver Biopsies
Volume 133, Issue 2, Pages (August 2007)
Ashwin N. Ananthakrishnan, David Lieberman  Gastroenterology 
This Month in Gastroenterology
This Month in Gastroenterology
Volume 148, Issue 3, Pages (March 2015)
Covering the Cover Gastroenterology
Volume 141, Issue 3, Pages (September 2011)
Jeremy P. Dwyer, Patrick Hosking, John Lubel  Gastroenterology 
Volume 149, Issue 6, Pages (November 2015)
Was That Last Colonoscopy Really Negative
This Month in Gastroenterology
Covering the Cover Gastroenterology
The Dawning of a New Editorial Board for Gastroenterology
Covering the Cover Gastroenterology
Volume 147, Issue 4, Pages (October 2014)
This Month in Gastroenterology
Risks Associated With Anesthesia Services During Colonoscopy
Volume 155, Issue 6, Pages (December 2018)
Volume 139, Issue 6, Pages e1 (December 2010)
Volume 138, Issue 6, Pages (May 2010)
Controversies in Liver Transplantation for Hepatitis C
Volume 135, Issue 5, Pages (November 2008)
Amir Klein, Michael J. Bourke  Gastroenterology 
Volume 156, Issue 4, Pages (March 2019)
Presentation transcript:

This Month in Gastroenterology Jan Tack, John M. Carethers  Gastroenterology  Volume 135, Issue 6, Pages 1827-1830 (December 2008) DOI: 10.1053/j.gastro.2008.11.007 Copyright © 2008 AGA Institute Terms and Conditions

Figure 1 Results from multivariate analysis showing the odds ratio for colonoscopy-related bleeding or perforation according to the annual colonoscopy volume of the endoscopist. Beside polypectomy, male gender, and older age, a procedure performed by a low-volume endoscopist was also an independent risk factor for these complications. Gastroenterology 2008 135, 1827-1830DOI: (10.1053/j.gastro.2008.11.007) Copyright © 2008 AGA Institute Terms and Conditions

Figure 2 Outcomes of drug-induced liver injury according to implicated agent, patient age, and pattern. No significant differences were observed in relation to these characteristics. Gastroenterology 2008 135, 1827-1830DOI: (10.1053/j.gastro.2008.11.007) Copyright © 2008 AGA Institute Terms and Conditions

Figure 3 Adenovirus rescue of the glucagon receptor in Gcgr−/− mice attenuates Jo2-induced apoptosis. (A) Fed-state levels of plasma glucagon in Gcgr−/− mice 5 days after intravenous administration of 1 × 109 pfu of either Ad-LacZ (control), or Ad-rGcgr (recombinant glucagons receptor); glucagon levels in nontransduced Gcgr−/− mice are also shown. Data are mean values ± standard error of the mean (n = 6–8 mice per group). ***P < .001, Ad-LacZ versus Ad-Gcgr–transduced Gcgr−/− mice or Gcgr+/+ mice. (B, C). Five days after administration of adenovirus as indicated in A, Gcgr−/− mice were injected with 10 μg Jo2 (n = 6–8 mice per group). After 4 hours, liver samples were taken for analysis. (B) Individual hepatic apoptosis scores were assessed. Horizontal line, median. (C) Immunohistochemical and quantitative detection of cleaved caspase-3 in liver sections from either Ad-LacZ– or Ad-rGcgr–infected Gcgr−/− mice after Jo2 administration (original magnification, 50×). Gastroenterology 2008 135, 1827-1830DOI: (10.1053/j.gastro.2008.11.007) Copyright © 2008 AGA Institute Terms and Conditions